Stephen Forman - Jun 30, 2021 Form 4 Insider Report for LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)

Role
Director
Signature
/s/ Stephen Forman
Stock symbol
LIXT
Transactions as of
Jun 30, 2021
Transactions value $
$0
Form type
4
Date filed
7/2/2021, 04:06 PM
Next filing
Aug 3, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LIXT Options to Purchase Common Stock Award $0 +100K $0.00 100K Jun 30, 2021 Common 100K $3.03 Direct F1
holding LIXT Options to Purchase Common Stock 50K Jun 30, 2021 Common 50K $3.21 Direct
holding LIXT Warrants to Purchase Common Stock 21.1K Jun 30, 2021 Common 21.1K $5.70 By Stephen Forman Living Trust
holding LIXT Options to Purchase Common Stock 33.3K Jun 30, 2021 Common 33.3K $0.96 Direct
holding LIXT Options to Purchase Common Stock 8.33K Jun 30, 2021 Common 8.33K $0.90 Direct
holding LIXT Options to Purchase Common Stock 8.33K Jun 30, 2021 Common 8.33K $6.60 Direct
holding LIXT Warrants to Purchase Common Stock 16.7K Jun 30, 2021 Common 16.7K $6.00 By Stephen Forman Living Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Effective June 30, 2021, the reporting person was granted stock options to purchase an aggregate of 100,000 shares, vesting in eight equal installments on the last day of each subsequent quarter until fully vested (e.g. vesting to start on September 20, 2021).